These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11429548)
1. TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Wang H; Marsters SA; Baker T; Chan B; Lee WP; Fu L; Tumas D; Yan M; Dixit VM; Ashkenazi A; Grewal IS Nat Immunol; 2001 Jul; 2(7):632-7. PubMed ID: 11429548 [TBL] [Abstract][Full Text] [Related]
2. Activation and accumulation of B cells in TACI-deficient mice. Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549 [TBL] [Abstract][Full Text] [Related]
3. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284 [TBL] [Abstract][Full Text] [Related]
5. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365 [TBL] [Abstract][Full Text] [Related]
6. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217 [TBL] [Abstract][Full Text] [Related]
7. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128 [TBL] [Abstract][Full Text] [Related]
9. The uncertain glory of APRIL. Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235 [TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291 [TBL] [Abstract][Full Text] [Related]
11. APRIL modulates B and T cell immunity. Stein JV; López-Fraga M; Elustondo FA; Carvalho-Pinto CE; Rodríguez D; Gómez-Caro R; De Jong J; Martínez-A C; Medema JP; Hahne M J Clin Invest; 2002 Jun; 109(12):1587-98. PubMed ID: 12070306 [TBL] [Abstract][Full Text] [Related]
12. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Mackay F; Schneider P Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565 [TBL] [Abstract][Full Text] [Related]
13. The role of APRIL and BAFF in lymphocyte activation. Schneider P Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118 [TBL] [Abstract][Full Text] [Related]
14. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625 [TBL] [Abstract][Full Text] [Related]
15. To switch or not to switch--the opposing roles of TACI in terminal B cell differentiation. Salzer U; Jennings S; Grimbacher B Eur J Immunol; 2007 Jan; 37(1):17-20. PubMed ID: 17171762 [TBL] [Abstract][Full Text] [Related]
16. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Xu S; Lam KP Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913 [TBL] [Abstract][Full Text] [Related]
17. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop. Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850 [TBL] [Abstract][Full Text] [Related]
18. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172 [TBL] [Abstract][Full Text] [Related]
19. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449 [TBL] [Abstract][Full Text] [Related]
20. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]